Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Non-Current Deferred Tax Liability came in at $53.5 million in Q1 2026, down 1.36% on a QoQ basis from $54.2 million in Q4 2025.
Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $53.5 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $53.5 million in Q1 2026; TTM through Mar 2026 was $53.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $53.5 million, down from $54.2 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for LNTH reached as high as $55.1 million in Q3 2025 and fell as low as $53.5 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.51 Mn |
| Mar 31, 2026 | 53.51 Mn |
| Dec 31, 2025 | 54.25 Mn |
| Dec 31, 2025 | 54.25 Mn |
| Sep 30, 2025 | 55.08 Mn |
| Sep 30, 2025 | 55.08 Mn |
| Dec 31, 2016 | 33.20 Mn |
| Dec 31, 2016 | 33.20 Mn |
| Mar 31, 2016 | 200,000.00 |
| Mar 31, 2016 | 200,000.00 |
| Dec 31, 2015 | 32.90 Mn |
| Dec 31, 2015 | 32.90 Mn |
| Dec 31, 2014 | 247,000.00 |
| Dec 31, 2014 | 247,000.00 |